These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7253772)

  • 41. Sex differences in the anorexigenic effects of dexfenfluramine and amphetamine in baboons.
    Foltin RW; Evans SM
    Exp Clin Psychopharmacol; 2018 Aug; 26(4):335-340. PubMed ID: 29792471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative study of the anorexigenic potency of some appetite depressants].
    Opitz K; Kemper F; Loeser A
    Arzneimittelforschung; 1965 Mar; 15(3):278-81. PubMed ID: 5897218
    [No Abstract]   [Full Text] [Related]  

  • 43. Partial purification of rat urinary anorexigenic substance.
    Lee YW; Lichton IJ
    J Nutr; 1973 Nov; 103(11):1616-24. PubMed ID: 4518590
    [No Abstract]   [Full Text] [Related]  

  • 44. Differential facilitation of food intake by food odour after pairing with amphetamine (first published in French in 1963).
    Le Magnen J; Julien N
    Appetite; 1999 Aug; 33(1):55-9. PubMed ID: 10447979
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anorexigenics. Experimental study methods, chemical structures and classification].
    Le Douarec JC
    Therapie; 1979; 34(2):131-53. PubMed ID: 386554
    [No Abstract]   [Full Text] [Related]  

  • 46. Anorexigenic effects of adrenaline, amphetamine, and FMS 1A.
    Russek M; Stevenson JA; Mogenson GJ
    Can J Physiol Pharmacol; 1968 Jul; 46(4):635-8. PubMed ID: 5243893
    [No Abstract]   [Full Text] [Related]  

  • 47. Trial of appetite suppressant. Study of a short-acting and sustained release appetite suppressant on patients paired by initial weight.
    LeRiche WH; Csima A
    Appl Ther; 1967 Mar; 9(3):260-2. PubMed ID: 6039128
    [No Abstract]   [Full Text] [Related]  

  • 48. Interactions of caffeine with various amphetamines on rat food consumption and avoidance responding.
    Cox RH; Maickel RP
    Neuropharmacology; 1976 Dec; 15(12):767-71. PubMed ID: 1012441
    [No Abstract]   [Full Text] [Related]  

  • 49. [On the anorexigenic action of cocaine].
    Schmidt G
    Arch Int Pharmacodyn Ther; 1965 Jul; 156(1):87-99. PubMed ID: 5858842
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapeutic activity and value of a delayed anorectic agent: amfepramone hydrochloride presented in microgranules].
    Linquette M; Fossati P
    Lille Med; 1971; 16(7):Suppl 3:902-8. PubMed ID: 5118952
    [No Abstract]   [Full Text] [Related]  

  • 51. [A follow-up study of amphetamine addicts participating in clinical drug studies].
    Gunne LM; Götestam KG
    Lakartidningen; 1972 Mar; 69(10):1103-5. PubMed ID: 5013950
    [No Abstract]   [Full Text] [Related]  

  • 52. Experimental anorexigenic effect of a membrane proteoglycan isolated from plants.
    Upreti RK; Ahmad S; Shukla S; Kidwai AM
    J Ethnopharmacol; 1994 Mar; 42(1):53-61. PubMed ID: 8046944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The trifluoromethylated N1-arylbiguanides, compounds of high hypoglycemic or anorexigenic activity; relation between structure and their 2 types of properties].
    Buu-Hoï NP; Béranger S; Jacquignon P; Krikorian-Manoukian A; Courmarcel D
    C R Acad Hebd Seances Acad Sci D; 1967 Sep; 265(13):930-3. PubMed ID: 4967863
    [No Abstract]   [Full Text] [Related]  

  • 54. [Anorexigenic activity of various derivatives of alpha-aminoacetophenone].
    Sánchez MS; Marín A; Forn J
    Arch Farmacol Toxicol; 1979 Dec; 5(3):165-8. PubMed ID: 546333
    [No Abstract]   [Full Text] [Related]  

  • 55. A new group of anorexigenic compounds.
    Freter K; Götz M; Oliver JT
    J Med Chem; 1970 Nov; 13(6):1228-30. PubMed ID: 5479875
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical study of a new anorexigenic].
    Plauchu M; Arnaud P; Pousset G
    Lyon Med; 1968 Jan; 219(2):111-7. PubMed ID: 5664949
    [No Abstract]   [Full Text] [Related]  

  • 57. [Ion exchange resins as carriers for oral medications in order to achieve sustained release. II].
    Berg PR; Ostrup P
    Dan Tidsskr Farm; 1966 Apr; 40(4):55-88. PubMed ID: 5915327
    [No Abstract]   [Full Text] [Related]  

  • 58. Polymer drug combinations. VI. Sustained release of levamisole from ion exchange resins.
    Schacht E; Goethals E; Gyselinck P; Thienpont D
    J Pharm Belg; 1982; 37(3):183-8. PubMed ID: 7131226
    [No Abstract]   [Full Text] [Related]  

  • 59. [Metabolism of (+) N-methyl N-(furyl-2methyl) phenylisopropylamine cyclohexylsulfamate (furfenonex cyclohexylsulfamate) in rats].
    Boissier JR; Hirtz J; Dumont C; Gérardin A
    Ann Pharm Fr; 1968 Mar; 26(3):215-26. PubMed ID: 5719761
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of Soviet-made anionites in the manufacture of delayed-action preparations].
    Ziubr TP; Maniak VA
    Farmatsiia; 1977; 26(4):54-5. PubMed ID: 902803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.